Pregled bibliografske jedinice broj: 1265081
Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting
Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting // Pharmacy (Basel), 11 (2023), 68, 12 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1265081 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antimicrobial Stewardship and Dose Adjustment of
Restricted Antimicrobial Drugs in Hospital Setting
Autori
Vlak, Iva ; Samardžić, Ivana ; Marinović, Ivana ; Bušić, Nikolina ; Bačić Vrca, Vesna
Izvornik
Pharmacy (Basel) (2226-4787) 11
(2023);
68, 12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Antimicrobial stewardship ; restricted antimicrobial drugs ; dose adjustment ; adverse drug reactions
Sažetak
Antimicrobial consumption is increasing. In order to maximize the effectiveness of antimicrobial stewardship and provide safe and optimal use of restricted antimicrobial drugs, renal dosing should be evaluated. The aim of this study was to determine the prevalence of restricted antimicrobial drugs that required dose adjustment according to renal function. A retrospective, consecutive study was conducted at University Hospital Dubrava. This study analyzed requests for restricted antimicrobial drugs (n = 2890) during a 3-month period. Requests for antimicrobial agents were evaluated by the antimicrobial therapy management team (A-team). This study included 412 restricted antimicrobial drug requests requiring dose adjustment, of which 39.1% did not have an adjusted dose. Meropenem, Ciprofloxacin, Piperacillin/Tazobactam, Vancomycin, Colistin and the antimycotic Fluconazole were the most frequent restricted antimicrobial drugs that required dose adjustment according to impaired renal function. The results of this research highlight the importance of the A-team in the optimization of restricted antimicrobial therapy. Non-adjusted doses of restricted antimicrobial drugs increase the possibility of adverse drug reactions and therefore jeopardize pharmacotherapy outcomes and patient safety.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus